Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000921895-20-002482
Filing Date
2020-09-28
Accepted
2020-09-28 16:37:32
Documents
2

Document Format Files

Seq Description Document Type Size
1 sc13d12566dug_09282020.htm SC 13D 53921
2 ex991to13d12566dug_09282020.htm EX-99.1 67817
  Complete submission text file 0000921895-20-002482.txt   123195
Mailing Address 611 SOUTH FORT HARRISON AVE SUITE 306 CLEARWATER FL 33756
Business Address
DUGGAN ROBERT W (Filed by) CIK: 0001055919 (see all company filings)

Type: SC 13D

Mailing Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142 617-514-7149
Summit Therapeutics Inc. (Subject) CIK: 0001599298 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-88759 | Film No.: 201204798
SIC: 2834 Pharmaceutical Preparations